US 9120811
6-(1H-indazol-6-YL)-N-(4-morpholinophenyl)imidazo[1,4-A]pyrazin-8-amine for treating leukemia or lymphoma
granted A61KA61K31/495A61P
Quick answer
US patent 9120811 (6-(1H-indazol-6-YL)-N-(4-morpholinophenyl)imidazo[1,4-A]pyrazin-8-amine for treating leukemia or lymphoma) held by GILEAD CONNECTICUT, INC. expires Mon Aug 27 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- GILEAD CONNECTICUT, INC.
- Grant date
- Tue Sep 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 27 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K31/495, A61P, A61P11/00, A61P11/02